ID
33648
Beschrijving
Study ID: 107434 Clinical Study ID: NAP107434 Study Title: A randomised, double-blind, double-dummy, placebo controlled, three-way cross-over study to investigate the effect of single oral doses of 100 mg GW273225 (4030W92) and 325 mg LAMICTAL on resting motor threshold in healthy subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Study Link: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: GW273225 Trade Name: lamictal Study Indication: Bipolar Disorder This form contains informations about the subjects eligibility. It should be filled out at each treatment period. Screening Visit: 28 days prior to first dosing. Treatment Period: The day before dosing, until 48h after dosing. Follow-Up: 14-21 days after last dose
Trefwoorden
Versies (3)
- 03-12-18 03-12-18 -
- 18-12-18 18-12-18 -
- 09-01-19 09-01-19 -
Houder van rechten
GlaxoSmithKline
Geüploaded op
18 december 2018
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Effect of Lamictal on Resting Motor Threshold Study-ID 107434
Eligibility Review on Admission
- StudyEvent: ODM
Beschrijving
Eligibility Review on Admission
Alias
- UMLS CUI-1
- C0013893
- UMLS CUI-2
- C0030673
Beschrijving
If No, please give the reason below
Datatype
boolean
Alias
- UMLS CUI [1]
- C0680251
- UMLS CUI [2]
- C1512693
Beschrijving
Comment if the subject does not satisfy the inclusion/exclusion criteria of this study protocol.
Datatype
text
Alias
- UMLS CUI [1,1]
- C0947611
- UMLS CUI [1,2]
- C0680251
- UMLS CUI [1,3]
- C0231175
- UMLS CUI [2,1]
- C0947611
- UMLS CUI [2,2]
- C1512693
- UMLS CUI [2,3]
- C0231175
Beschrijving
Sponsor contacted about Eligibility
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0332158
- UMLS CUI [1,2]
- C2347796
- UMLS CUI [1,3]
- C0013893
Beschrijving
Comment if the sponsor was contacted about the subject’s eligibility
Datatype
text
Alias
- UMLS CUI [1,1]
- C0947611
- UMLS CUI [1,2]
- C0332158
- UMLS CUI [1,3]
- C2347796
- UMLS CUI [1,4]
- C0013893
- UMLS CUI [1,5]
- C0231175
Beschrijving
Proceed Dosage
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0178602
- UMLS CUI [1,2]
- C0549178
Beschrijving
Comment if the subject will not proceed to dosing?
Datatype
text
Alias
- UMLS CUI [1,1]
- C0947611
- UMLS CUI [1,2]
- C0178602
- UMLS CUI [1,3]
- C0549178
- UMLS CUI [1,4]
- C0947611
- UMLS CUI [1,5]
- C0231175
Beschrijving
Eligibility Review
Datatype
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C0013893
Beschrijving
Physician's Initials
Datatype
text
Alias
- UMLS CUI [1,1]
- C2986440
- UMLS CUI [1,2]
- C0031831
Beschrijving
Informed Consent
Alias
- UMLS CUI-1
- C0021430
Beschrijving
Informed Consent Obtained
Datatype
boolean
Alias
- UMLS CUI [1]
- C0021430
Beschrijving
Informed Consent Date
Datatype
date
Alias
- UMLS CUI [1,1]
- C0021430
- UMLS CUI [1,2]
- C0011008
Beschrijving
Physician's Initials
Datatype
text
Alias
- UMLS CUI [1,1]
- C2986440
- UMLS CUI [1,2]
- C0031831
Beschrijving
Conclusion
Alias
- UMLS CUI-1
- C1707478
Similar models
Eligibility Review on Admission
- StudyEvent: ODM
C0600091 (UMLS CUI [1,2])
C0030673 (UMLS CUI-2)
C1512693 (UMLS CUI [2])
C0680251 (UMLS CUI [1,2])
C0231175 (UMLS CUI [1,3])
C0947611 (UMLS CUI [2,1])
C1512693 (UMLS CUI [2,2])
C0231175 (UMLS CUI [2,3])
C2347796 (UMLS CUI [1,2])
C0013893 (UMLS CUI [1,3])
C0332158 (UMLS CUI [1,2])
C2347796 (UMLS CUI [1,3])
C0013893 (UMLS CUI [1,4])
C0231175 (UMLS CUI [1,5])
C0549178 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,2])
C0549178 (UMLS CUI [1,3])
C0947611 (UMLS CUI [1,4])
C0231175 (UMLS CUI [1,5])
C0013893 (UMLS CUI [1,2])
C0031831 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0031831 (UMLS CUI [1,2])
C1552089 (UMLS CUI [1,2])
Geen commentaren